0001193125-15-126135.txt : 20150512 0001193125-15-126135.hdr.sgml : 20150512 20150410161835 ACCESSION NUMBER: 0001193125-15-126135 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20150410 FILER: COMPANY DATA: COMPANY CONFORMED NAME: XBiotech Inc. CENTRAL INDEX KEY: 0001626878 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 8201 E. RIVERSIDE DRIVE STREET 2: BUILDING 4, SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78744 BUSINESS PHONE: 512-386-2930 MAIL ADDRESS: STREET 1: 8201 E. RIVERSIDE DRIVE STREET 2: BUILDING 4, SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78744 CORRESP 1 filename1.htm Correspondence

April 10, 2015

VIA EDGAR

Securities and Exchange Commission

Division of Corporate Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention: Jeffrey P. Riedler
Alla Berenshteyn

 

Re: XBiotech Inc.

Registration Statement on Form S-1, as amended

File No. 333-201813

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), the undersigned, W.R. Hambrecht + Co., LLC, as the underwriter of the offering pursuant to the above-referenced Registration Statement on Form S-1, as amended (the “Registration Statement”), hereby joins in the request of XBiotech Inc. that the effective date of the Registration Statement be accelerated so that the Registration Statement becomes effective at 1:00 p.m. (Eastern time) on April 14, 2015 or as soon thereafter as practicable.

In connection with this acceleration request and pursuant to Rule 460 under the Securities Act, the following information is provided with respect to the distribution of the preliminary prospectus included in the Registration Statement during the period of March 27, 2015 to April 10, 2015:

To Whom Distributed

Prospective underwriters, dealers, institutional investors and others

Number of copies

850

In connection with the preliminary prospectus distribution, we are complying with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

 

Very truly yours,
W.R. Hambrecht + Co., LLC
By: W.R. Hambrecht + Co., LLC
By

/s/ Whitney White

Authorized Officer